710 related articles for article (PubMed ID: 27683128)
1. Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion.
Wang H; Stoecklein NH; Lin PP; Gires O
Oncotarget; 2017 Jan; 8(1):1884-1912. PubMed ID: 27683128
[TBL] [Abstract][Full Text] [Related]
2. Clinical and biological significance of circulating tumor cells in cancer.
Masuda T; Hayashi N; Iguchi T; Ito S; Eguchi H; Mimori K
Mol Oncol; 2016 Mar; 10(3):408-17. PubMed ID: 26899533
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumor cells and their advances to promote cancer metastasis and relapse, with focus on glioblastoma multiforme.
Chistiakov DA; Chekhonin VP
Exp Mol Pathol; 2018 Oct; 105(2):166-174. PubMed ID: 30028961
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
[TBL] [Abstract][Full Text] [Related]
5. Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy.
Kasimir-Bauer S; Bittner AK; König L; Reiter K; Keller T; Kimmig R; Hoffmann O
Breast Cancer Res; 2016 Feb; 18(1):20. PubMed ID: 26868521
[TBL] [Abstract][Full Text] [Related]
6. Functional studies on circulating and disseminated tumor cells in carcinoma patients.
Alix-Panabières C; Bartkowiak K; Pantel K
Mol Oncol; 2016 Mar; 10(3):443-9. PubMed ID: 26847851
[TBL] [Abstract][Full Text] [Related]
7. Current challenges in metastasis: disseminated and circulating tumor cells detection.
Shahneh FZ
Hum Antibodies; 2013; 22(3-4):77-85. PubMed ID: 24961866
[TBL] [Abstract][Full Text] [Related]
8. Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis.
Liu X; Li J; Cadilha BL; Markota A; Voigt C; Huang Z; Lin PP; Wang DD; Dai J; Kranz G; Krandick A; Libl D; Zitzelsberger H; Zagorski I; Braselmann H; Pan M; Zhu S; Huang Y; Niedermeyer S; Reichel CA; Uhl B; Briukhovetska D; Suárez J; Kobold S; Gires O; Wang H
Sci Adv; 2019 Jun; 5(6):eaav4275. PubMed ID: 31223646
[TBL] [Abstract][Full Text] [Related]
9. Evidence for circulating cancer stem-like cells and epithelial-mesenchymal transition phenotype in the pleurospheres derived from lung adenocarcinoma using liquid biopsy.
Mirza S; Jain N; Rawal R
Tumour Biol; 2017 Mar; 39(3):1010428317695915. PubMed ID: 28347243
[TBL] [Abstract][Full Text] [Related]
10. Genetic traits for hematogeneous tumor cell dissemination in cancer patients.
Joosse SA; Pantel K
Cancer Metastasis Rev; 2016 Mar; 35(1):41-8. PubMed ID: 26931653
[TBL] [Abstract][Full Text] [Related]
11. Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack.
Bulfoni M; Turetta M; Del Ben F; Di Loreto C; Beltrami AP; Cesselli D
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27783057
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumor cells (CTCs) as a liquid biopsy material and drug target.
Cai LL; Ye HM; Zheng LM; Ruan RS; Tzeng CM
Curr Drug Targets; 2014; 15(10):965-72. PubMed ID: 25182470
[TBL] [Abstract][Full Text] [Related]
13. Phenotype of circulating tumor cell: face-off between epithelial and mesenchymal masks.
Hong Y; Zhang Q
Tumour Biol; 2016 May; 37(5):5663-74. PubMed ID: 26758432
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor cells as Trojan Horse for understanding, preventing, and treating cancer: a critical appraisal.
Mentis AA; Grivas PD; Dardiotis E; Romas NA; Papavassiliou AG
Cell Mol Life Sci; 2020 Sep; 77(18):3671-3690. PubMed ID: 32333084
[TBL] [Abstract][Full Text] [Related]
15. The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells.
Kölbl AC; Jeschke U; Andergassen U
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27529216
[TBL] [Abstract][Full Text] [Related]
16. Expression profiling of circulating tumor cells in metastatic breast cancer.
Lang JE; Scott JH; Wolf DM; Novak P; Punj V; Magbanua MJ; Zhu W; Mineyev N; Haqq CM; Crothers JR; Esserman LJ; Tripathy D; van 't Veer L; Park JW
Breast Cancer Res Treat; 2015 Jan; 149(1):121-31. PubMed ID: 25432738
[TBL] [Abstract][Full Text] [Related]
17. Biology and significance of circulating and disseminated tumour cells in colorectal cancer.
Steinert G; Schölch S; Koch M; Weitz J
Langenbecks Arch Surg; 2012 Apr; 397(4):535-42. PubMed ID: 22350614
[TBL] [Abstract][Full Text] [Related]
18. Metabolic classification of circulating tumor cells as a biomarker for metastasis and prognosis in breast cancer.
Chen J; Ye C; Dong J; Cao S; Hu Y; Situ B; Xi X; Qin S; Xu J; Cai Z; Zheng L; Wang Q
J Transl Med; 2020 Feb; 18(1):59. PubMed ID: 32028979
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumor cells in breast cancer--current status and perspectives.
Banys-Paluchowski M; Krawczyk N; Meier-Stiegen F; Fehm T
Crit Rev Oncol Hematol; 2016 Jan; 97():22-9. PubMed ID: 26563820
[TBL] [Abstract][Full Text] [Related]
20. Epithelial-mesenchymal plasticity in circulating tumor cells.
Alix-Panabières C; Mader S; Pantel K
J Mol Med (Berl); 2017 Feb; 95(2):133-142. PubMed ID: 28013389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]